Segments - Laparoscopic Surgery Devices Market by Applications (Colorectal Surgery, General Surgery, Gynecological Surgery, Urological Surgery, Bariatric Surgery, and Other Surgeries), Products (Hand Access Instruments, Robot Assisted Systems, Insufflation Device, Suction/ Irrigation Device, Closure Devices, Trocars, Energy Systems, and Laparoscopes), End-users (Ambulatory, Clinic, and Hospital), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2022 – 2030
The laparoscopic surgery devices market size was valued at USD 6.8 billion in 2021 and is projected to reach USD 12.6 billion by 2030, expanding at a CAGR of around 7.2% during the forecast period, 2022 – 2030. The growth of the market is attributed to rising prevalence of obesity among all age categories, as well as the fast-growing elderly population.
Laparoscopy is a surgical procedure that involves making small incisions in the body such as the abdominal wall, which can be used to insert a laparoscope and other tools to view structures within the interior body cavity. As it moves into the abdomen, the camera sends photos to a monitor. Fibroids, cysts, pelvic inflammatory disease (PID), ectopic pregnancy, and endometriosis are all treated using laparoscopy. Laparoscopy devices are commonly employed in the diagnosis and treatment of a variety of ailments, including gastrointestinal issues, pancreatic cancer, and prostatectomy. These devices are used in surgical procedures to help maintain hemostasis and prevent bleeding. Due of the great level of precision provided by such devices in procedures, surgeons and physicians prefer them.
During the COVID-19, hospitals around the world decreased optional and non-urgent cases in order to maintain social distance and prevent virus transmission. However, essential cancer and gynecological surgeries were being conducted, and it is essential that all medical workers be protected, as well as the risk of virus infection when treating on asymptomatic or diagnosed COVID-19 patients. Almost all the industries were affected due to COVID-19. However, over the forecast period, the market for the laparoscopic surgery device is estimated to revive and increase, as most governments around the world have begun to ease lockdown restrictions and resume some elective procedures. Companies are sourcing from additional partners, flying freight delivery, and rerouting logistics, to deal with supply chain delays. The pandemic has also benefitted local manufacturers. These characteristics are projected to create lucrative opportunities for the market growth.
The report on the global laparoscopic surgery devices market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Laparoscopic Surgery Devices Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2021 |
Historic Data |
2019–2020 |
Forecast Period |
2022 – 2030 |
Segmentation |
Applications (Colorectal Surgery, General Surgery, Gynecological Surgery, Urological Surgery, Bariatric Surgery, and Other Surgeries), Products (Hand Access Instruments, Robot Assisted Systems, Insufflation Device, Suction/ Irrigation Device, Closure Devices, Trocars, Energy Systems, and Laparoscopes), End-users (Ambulatory, Clinic, and Hospital), |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players Covered in the Report |
Shenzen Mindray Bio-Medical Electronics Co., Ltd.; Intuitive Surgical; DEAM; Welfare Medical Ltd; BD; Microline Surgical; Richard Wolf GmbH; The Cooper Companies Inc.; B. Braun Melsungen AG; CONMED Corporation; Olympus Corporation; Johnson and Johnson; Medtronic; Karl Storz SE & CO. Kg; Boston Scientific Corporation; and Stryker Corporation. |
Based on applications, the market is segregated into colorectal surgery, general surgery, gynecological surgery, urological surgery, bariatric surgery, and other surgeries. The general surgery segment dominated the market in 2021 owing to rising cases of surgical removal of appendix, patients suffering from hernia, and removal of gall bladder. The bariatric surgery segment is projected to grow at a rapid pace during the forecast period owing to its potential for treating diabetes and disorders related to cardiovascular disease. Furthermore, laparoscopic bariatric surgery aids in the treatment of obesity-related diseases such sleep apnea, high cholesterol, high blood pressure, and type 2 diabetes.
On the basis of products, the market is fragmented into hand access instruments, robot assisted systems, insufflation device, suction/ irrigation device, closure devices, trocars, energy systems, and laparoscopes. The energy systems segment held around 21% of the total market share in 2021. During laparoscopic surgery, energy systems enable coagulation, transection, and quick tissue & vascular sealing. These devices benefit in the procedures such as biliopancreatic diversion with duodenal, adjustable gastric band, sleeve gastrectomy, and gastric bypass. The insufflation device segment is projected to expand at a high CAGR during the forecast period. Persufflation of the abdominal cavity with humidified carbon dioxide is simple and safe with insufflation equipment. The increased prevalence and incidence of diseases such colorectal cancer is projected to fuel the segment.
In terms of end-users, the market is divided into ambulatory, clinic, and hospital. The hospitals segment accounted for a major market share in 2021. The rise in surgical procedures attributed to growth in the number of people suffering from chronic conditions. Hospitals encounter a substantially higher inflow of patients for bariatric surgery or other laparoscopic procedures than other healthcare settings due to the convenience with which any complications that may occur during surgical procedures can be handled and the extensive range of treatment alternatives available. As a result, hospitals have a higher need for laparoscopic devices than other end-user segments. The ambulatory segment is projected to expand at a high CAGR during the forecast period. Growth of the segment is attributed to rising use of minimally invasive surgeries and strong desire for outpatient services.
On the basis of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. The market in Asia Pacific is anticipated to expand at a robust CAGR during the forecast period owing to growing number of well-equipped and modern hospitals in the region. Growth of the market in the region is attributed to increased medical tourism, improved reimbursement scenarios, increased investment, and advances in technology. North America dominated the market in 2021. Increased healthcare spending in the US is estimated to encourage both new and old competitors to enter the market.
The global laparoscopic surgery devices market has been segmented on the basis of
ApplicationsKey players competing in the laparoscopic surgery devices market include Shenzen Mindray Bio-Medical Electronics Co., Ltd.; Intuitive Surgical; DEAM; Welfare Medical Ltd; BD; Microline Surgical; Richard Wolf GmbH; The Cooper Companies Inc.; B. Braun Melsungen AG; CONMED Corporation; Olympus Corporation; Johnson and Johnson; Medtronic; Karl Storz SE & CO. Kg; Boston Scientific Corporation; and Stryker Corporation. Some of these players are using several market strategies such as acquisitions, mergers, collaborations, partnerships, capacity expansion, and product launches to enhance their market shares, generate revenue, and raise their production line of the business in the coming years.
The laparoscopic surgery devices market size was valued at USD 6.8 billion in 2021.
The laparoscopic surgery devices market is projected to expand at a CAGR of around 7.2% during the forecast period, 2022 – 2030.
The energy systems segment held around 21% of the total market share in 2021.
Asia Pacific is projected to register a high CAGR during the forecast period
Some of the top players in the market include Medtronic; Karl Storz SE & CO. Kg; Boston Scientific Corporation; and Stryker Corporation.